Alkermes Plc (ALKS) earnings · P/E 108, rev $1.48B
These earnings events as JSON? API free 100/dayAlkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
This ALKS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ALKS revenue for 2025-12-31 was $1.48B. Net income was $241.7M. Revenue was down 5.2% from 2024-12-31 to 2025-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 108.5.
When the next ALKS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 5.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ALKS research stays on the stock page; the tape stays on the quote page.
ALKS earnings FAQ
What are ALKS's latest revenue and net income?
Latest cached Alkermes Plc (ALKS) revenue for Dec 31, 2025 was $1.48B. Net income was $241.7M. Statements: https://lician.com/financials/alks
What is ALKS's latest diluted EPS?
Latest cached Alkermes Plc (ALKS) diluted EPS for Dec 31, 2025 was $1.43.
What period does the latest ALKS earnings print cover?
The latest cached Alkermes Plc (ALKS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ALKS revenue change from the prior cached period?
Cached Alkermes Plc (ALKS) revenue was down 5.2% from $1.56B (Dec 31, 2024) to $1.48B (Dec 31, 2025). Statements: https://lician.com/financials/alks
What is ALKS's P/E ratio?
Alkermes Plc (ALKS) trailing P/E is 108.5 on the latest cached fundamentals snapshot.
Where are ALKS earnings listed?
Cached earnings facts for Alkermes Plc (ALKS) are listed at https://lician.com/earnings/alks. Statements: https://lician.com/financials/alks
Not investment advice.